LITS Company Profile and Key Details

Short-term trend indicators are bullishly aligned (SMA20 3.49%, SMA50 -11.26%, SMA200 -55.15%). The stock’s 14-day RSI is 46.66 (neutral), while the ATR of 0.09 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -87.33% below its high and over 19.87% above its low. Average 10-day trading volume of 391.89 thousand shares is in line with the 3-month average of 394.75 thousand, indicating normal recent market interest.

Lite Strategy, Inc. generated EPS of -$1.74 over the past year. Five-year average earnings growth is 25.03%. Lite Strategy, Inc. earnings surprise history is a mixed track record. The quarter that ended May 13, 2026, missed forecasts by -78.82%. The prior quarter beat by -81.74%. Over the last six quarters, Apple has recorded several small beats. These include 17.45% in February 13, 2024.

Lite Strategy, Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $2.70. This means the shares are trading below this model’s fair value.

Lite Strategy, Inc. (NASDAQ:LITS) closed at $0.90 USD, gaining $0.08 (9.89%) from the previous close of $0.82. The stock is currently mid-range between its 52-week high and low $0.69 and $9.00. With a market capitalization of about $30.55 million, Lite Strategy, Inc. is classified as a micro-cap and shows lower-than-market volatility (beta ~0.04). Key stats such as the average daily volume over the past year has been around 400.08 thousand shares, in line with its 52-week average. Headquartered in San Diego, CA, Lite Strategy, Inc. operates in the Financial Services sector and the Asset Management - Cryptocurrency industry. Led by CEO Justin J. File, the company employs approximately 4 people and listed since December 18, 2003. Lite Strategy, Inc. functions as a clinical-stage pharmaceutical firm, concentrating its efforts on creating innovative and distinct therapeutic solutions for cancer patients.

Lite Strategy, Inc. (NASDAQ:LITS) shares are flat -0.76% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows Lite Strategy, Inc. trading at a premium to the broader market with a P/E of -0.09. Our AI forecast model points to short-term weakness (-4.23% over two weeks), a medium-term fall (-75.5% over three months), and a longer-term loss (-59.91% over one year), with expected trading ranges indicating moderate volatility.

Our AI price prediction model suggests that Lite Strategy, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -4.23%, with price expected at $0.86 by July 10, 2026, within a range of $0.79 to $0.94 3-Month Outlook: Projected fall of -75.5%, reaching $0.22 by September 24, 2026, with a range of $0.19 to $0.25. 1-Year Outlook: Projected loss of -59.91%, with price at $0.36 by June 25, 2027, within a range of $0.31 to $0.40.

Lite Strategy, Inc. trades at a P/E ratio of -0.09, slightly below the S&P 500 average, with a price-to-sales ratio of 0.0 and a price-to-book ratio of 0.1 suggesting the stock is closer to book value. The P/FCF stands at -2.82, also below market averages.